Parameter | Visual analogue scale | Time trade-off | ||||
---|---|---|---|---|---|---|
Coefficient | (SE) | p-value | Coefficient | (SE) | p-value | |
General population | Â | Â | Â | Â | Â | Â |
Intercept = moderate COPD | 0.750 | 0.009 | <0.0001 | 0.824 | 0.011 | <0.0001 |
Severe COPD | −0.179 | 0.005 | <0.0001 | −0.178 | 0.006 | <0.0001 |
Very severe COPD | −0.482 | 0.005 | <0.0001 | −0.519 | 0.006 | <0.0001 |
One non-serious exacerbation | −0.078 | 0.004 | <0.0001 | −0.082 | 0.005 | <0.0001 |
One serious exacerbation | −0.155 | 0.005 | <0.0001 | −0.164 | 0.006 | <0.0001 |
One non-serious and one serious exacerbation | −0.217 | 0.005 | <0.0001 | −0.228 | 0.006 | <0.0001 |
Generalized R2 | 0.83 | Â | Â | 0.86 | Â | Â |
MAE, mean (SD) | 0.008 | (0.006) | Â | 0.008 | (0.007) | Â |
Health professionals | Â | Â | Â | Â | Â | Â |
Intercept = moderate COPD | 0.759 | 0.027 | <0.0001 | 0.883 | 0.025 | <0.0001 |
Severe COPD | −0.226 | 0.014 | <0.0001 | −0.234 | 0.016 | <0.0001 |
Very Severe COPD | −0.496 | 0.014 | <0.0001 | −0.590 | 0.016 | <0.0001 |
One non-serious exacerbation | −0.072 | 0.012 | <0.0001 | −0.070 | 0.014 | <0.0001 |
One serious exacerbation | −0.147 | 0.014 | <0.0001 | −0.148 | 0.017 | <0.0001 |
One non-serious and one serious exacerbation | −0.196 | 0.014 | <0.0001 | −0.207 | 0.017 | <0.0001 |
Generalized R2 | 0.93 | Â | Â | 0.88 | Â | Â |
MAE, mean (SD) | 0.004 | (0.003) | Â | 0.011 | (0.008) | Â |